Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Reliant Pharmaceuticals

Reliant Pharmaceuticals, LLC, is a rapidly growing, privately held pharmaceutical company marketing branded, patent-protected pharmaceutical products to U.S.-based primary care and targeted specialty physicians.

Reliant acquires, develops, and markets products with the potential to significantly improve the treatment and management of diseases affecting large sectors of the population. These products have been underpromoted at their pharmaceutical originators, thus giving up market share to heavily promoted products. Reliant believes these products, based upon their safety and efficacy profiles, have the opportunity to grow with renewed promotion. Our sales and marketing programs are built on directed communications to the physicians, including showcasing and supporting Reliant’s products through a variety of mediums. We also work closely with the managed care industry to develop and implement programs that will improve the quality of patient care. By building strong relationships between Reliant, its physician audience, the patients who use its products, the industry’s key opinion leaders, and the managed care payors, we will only strengthen Reliant’s reputation in the healthcare industry.


Contact Details:
110 Allen Road
Liberty Corner
NJ
07938
United States of America
Tel:(908) 580-1200
Fax:(908) 542-9405
Email:
WWW:

www.reliantrx.com/




Loading...

Press Releases on Reliant Pharmaceuticals:

BioPortfolio Logo
Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR 21st April, 2009 Par Pharmaceutical Companies, Inc.
WOODCLIFF LAKE, N.J., April 21 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) ("Par") today announced it has entered into a settlement agreement with Reliant
Halo Pharmaceutical Welcomes Dr. George Bobotas as Its Chief Scientific Officer 20th April, 2009 Halo Pharmaceutical
WHIPPANY, N.J., April 20 /PRNewswire/ -- As part of a Research and Development partnership between Halo Pharmaceutical and DeMelleBioPharma, LLC, Dr. George Bobotas joins Halo Pharmaceutical as Chief
Dr. Roddy Carter Named President and Chief Executive Officer of WellGen, Inc. 7th April, 2009 WellGen, Inc.
NORTH BRUNSWICK, N.J., April 7 /PRNewswire/ -- WellGen, Inc. today announced that Dr. Roderick (Roddy) Carter, M.D., M.Sc., has been appointed President and Chief Executive Officer. Dr. Carter, 45
Covance Elects Bradley T. Sheares to Company's Board of Directors 19th February, 2009 Covance Inc.
PRINCETON, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it has elected Bradley T. Sheares, Ph. D., to its Board of Directors. Dr. Sheares is former chief
New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4th September, 2008 GlaxoSmithKline
PHILADELPHIA, Sept. 4 /PRNewswire/ -- Results from a new international study, the GISSI Heart Failure (GISSI-HF) study, showed that 1 g/d dose of omega-3 acid ethyl esters reduced all cause

BioNews Results for Reliant Pharmaceuticals:

Venezuela Pharmaceuticals And Healthcare Report Q4 2009: By 2013, The Venezuelan Pharmaceutical Market Will Be Worth VEB 26.0bn
OfficialWire:  Nov 7 2009 4:53AM Matching: reliant pharmaceuticals
CED Sets Dates For Upcoming Conference Season
Drug Discovery Online:  Nov 5 2009 4:13AM Matching: reliant pharmaceuticals
Venezuela Pharmaceuticals and Healthcare Report Q4 2009 - new report released
PR inside:  Nov 4 2009 7:26AM Matching: reliant pharmaceuticals
GlaxoSmithKline Q3 Profit Rises On Higher Sales - Update
Quote.com United Kingdom:  Oct 29 2009 5:43AM Matching: reliant pharmaceuticals
GlaxoSmithKline Q3 Profit Rises On Higher Sales - Update
Quote.com Japan:  Oct 28 2009 6:36PM Matching: reliant pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Reliant Pharmaceuticals news.

Reliant Pharmaceuticals Clinical Trials:

Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides

Reliant Pharmaceuticals Patents:

US Patent No.Title
7419684 System and method for manufacturing oral osmotic drug delivery devices, and methods of administering same
6930119 Liquid pharmaceutical composition

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 281 times since April 2007, the link to the organisation's website has been followed 62 times

Search for more companies in Liberty Corner

Search for more companies in NJ



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Reliant Pharmaceuticals

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.